Neuro-Optimized Shock Wave Generator for Enhanced Therapeutic Effect

A next-generation shock wave generator that leverages AI-driven pulse control and real-time feedback to optimize therapeutic outcomes, offering unparalleled precision and adaptability in shock wave therapy.

The original patent disclosed an apparatus for generating therapeutic shock waves with improved electrode lifetime. However, the existing technology lacks the ability to dynamically adjust shock wave frequency and amplitude in response to real-time feedback, limiting its therapeutic potential. The new inventive concept addresses this limitation by integrating neural network-based control modules and machine learning algorithms to optimize shock wave treatment.

The neuro-optimized shock wave generator comprises a housing defining a chamber and a shockwave outlet, a liquid disposed in the chamber, a plurality of electrodes configured to define one or more spark gaps, and a pulse generation system. The pulse generation system is configured to apply voltage pulses to the electrodes at a rate of between 10 Hz and 10 MHz and includes a neural network-based control module for optimizing shock wave frequency and amplitude based on real-time feedback from sensors monitoring the shock wave's therapeutic effect. The system's modular design enables easy upgrade or replacement of components with advanced technologies. The inventive concept also encompasses a method for generating therapeutic shock waves, which involves filling a chamber with a liquid, disposing electrodes to define spark gaps, applying voltage pulses, and using a machine learning algorithm to predict and adjust the shock wave frequency and amplitude based on historical data of the shock wave's therapeutic effect.

The new inventive concept introduces the use of neural network-based control modules and machine learning algorithms to optimize shock wave frequency and amplitude in real-time, providing a paradigm shift in shock wave therapy. This innovation enables the system to adapt to individual patient needs and optimize therapeutic outcomes, making it a significant advancement over the original patent.

Alternative embodiments of the inventive concept may include the use of different types of sensors, such as pressure sensors or accelerometers, to monitor the shock wave's therapeutic effect. Variations of the system could also incorporate additional components, such as cooling systems or advanced materials, to further enhance its performance and versatility.

The neuro-optimized shock wave generator has vast commercial potential in the medical device industry, particularly in the fields of orthopedics, physiotherapy, and sports medicine. The system's ability to optimize therapeutic outcomes and adapt to individual patient needs makes it an attractive solution for healthcare providers and patients alike, with a projected market size of over $1 billion in the next five years.